Recombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech)

重组人表皮生长因子衍生物（深圳市华生元基因工程）

Report date: 2025/12/12 16:46:07

Base Information

Drug NameRecombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech)
Drug Alias Name重组表皮生长因子衍生物Recombinant Human Epidermal Growth Factor Derivative Eye Drops重组人表皮生长因子衍生物滴眼剂rEGF derivativie人表皮生长因子（ARI加长型）滴眼液 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCorneal Diseases
Global Approved IndicationsCorneal Diseases
Approved Indications in ChinaCorneal Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2004/01/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Watsin Genetech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Watsin Genetech Ltd
Inactive CompaniesN/A
Active IndicationsCorneal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A